News from the catapult network

News headlines from across the Catapult Network. For comprehensive news updates, please explore our Politics Home webpage or visit individual Catapult websites

Graphic of four images including a microscope, a solar panel, a man examining a samply and a flying drone
Catapult Network
NEWS
Catapulting growth in 2023 and beyond
In the face of many challenges – changing customer desires, cost pressures, supply chain disruption, expected regulatory changes and fierce competition – UK innovation is on the rise. This article showcases how Catapults helped to deliver great results for business and industry in 2023; it summarises our predictions for technology-driven advances in 2024 and the years ahead.
Read more
Medicines Discovery
alt=
News
Turning Nuclear Waste into Breakthrough Cancer Treatments
United Kingdom National Nuclear Laboratory (UKNNL) and Medicines Discovery Catapult have received funding from UK Research and Innovation (UKRI) to drive the development of innovative approaches for new cancer treatments. The funding allows UKNNL and Medicines Discovery Catapult to finalise the case to scale up the harvesting of precision nuclear medicines from the UK’s spent nuclear material, providing global nuclear and healthcare leadership with sovereign capacity in this important therapeutic sector.
Read more
Medicines Discovery
News
Turning Nuclear Waste into Breakthrough Cancer Treatments
United Kingdom National Nuclear Laboratory (UKNNL) and Medicines Discovery Catapult have received funding from UK Research and Innovation (UKRI) to drive the development of innovative approaches for new cancer treatments. The funding allows UKNNL and Medicines Discovery Catapult to finalise the case to scale up the harvesting of precision nuclear medicines from the UK’s spent nuclear material, providing global nuclear and healthcare leadership with sovereign capacity in this important therapeutic sector.
Read more
Medicines Discovery
A microorganism
News
Medicines Discovery Catapult Publishes First Year of ESG Progress
Medicines Discovery Catapult has published its first Environmental, Social and Governance (ESG) Report, covering the period of October 2023 to September 2024. Medicines Discovery Catapult reshapes drug discovery for patient benefit, by transforming great UK science into better treatments, through partnership. The organisation delivers positive impact in its role as a national Life Sciences service and is committed to acting in a safe and responsible way whilst doing so.
Read more